| fibrinolysis | GO:0042730 | 3 | 0.508 | |
| protein maturation | GO:0051604 | 176 | 0.497 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.484 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.438 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.399 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.370 | |
| oxidation reduction process | GO:0055114 | 342 | 0.304 | |
| blood coagulation | GO:0007596 | 76 | 0.292 | Human |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.290 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.289 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.288 | |
| protein processing | GO:0016485 | 163 | 0.286 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.280 | |
| sterol metabolic process | GO:0016125 | 58 | 0.279 | Mouse |
| regulation of proteolysis | GO:0030162 | 164 | 0.269 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.260 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.248 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.239 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.237 | Mouse |
| regulation of blood coagulation | GO:0030193 | 28 | 0.214 | |
| regulation of protein processing | GO:0070613 | 96 | 0.213 | |
| hemostasis | GO:0007599 | 78 | 0.209 | Human |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.202 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.189 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.186 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.184 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.169 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.163 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.156 | |
| coagulation | GO:0050817 | 78 | 0.154 | Human |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.150 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.147 | Mouse |
| negative regulation of coagulation | GO:0050819 | 11 | 0.143 | |
| circulatory system process | GO:0003013 | 197 | 0.141 | Human |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.134 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.130 | |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.129 | |
| wound healing | GO:0042060 | 157 | 0.125 | Human |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.121 | |
| negative regulation of hemostasis | GO:1900047 | 11 | 0.111 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.110 | Mouse |
| cell adhesion | GO:0007155 | 329 | 0.109 | Human |
| regulation of response to wounding | GO:1903034 | 189 | 0.107 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.103 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.100 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.097 | |
| mapk cascade | GO:0000165 | 281 | 0.094 | Human |
| negative regulation of blood coagulation | GO:0030195 | 11 | 0.091 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.089 | Mouse |
| regulation of hormone levels | GO:0010817 | 211 | 0.087 | Human |
| macromolecule glycosylation | GO:0043413 | 55 | 0.085 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.083 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.083 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.083 | Rat |
| muscle cell differentiation | GO:0042692 | 261 | 0.080 | |
| regulation of wound healing | GO:0061041 | 40 | 0.080 | |
| immune effector process | GO:0002252 | 321 | 0.077 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.077 | |
| inflammatory response | GO:0006954 | 244 | 0.076 | |
| amine metabolic process | GO:0009308 | 45 | 0.075 | |
| positive regulation of protein kinase c activity | GO:1900020 | 1 | 0.075 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.074 | Human |
| negative regulation of lipoprotein lipase activity | GO:0051005 | 1 | 0.074 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.072 | |
| regulation of defense response | GO:0031347 | 233 | 0.072 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.071 | Human |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.069 | |
| lipid catabolic process | GO:0016042 | 69 | 0.069 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.069 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.067 | |
| complement activation | GO:0006956 | 16 | 0.066 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.065 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.065 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.065 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.064 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.064 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.062 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.062 | |
| regulation of complement activation | GO:0030449 | 7 | 0.062 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.061 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.059 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.055 | Mouse |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.055 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.054 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.053 | Human |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.053 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.052 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.052 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.052 | |
| angiogenesis | GO:0001525 | 201 | 0.051 | |
| regulation of serine type endopeptidase activity | GO:1900003 | 2 | 0.051 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.050 | |
| maintenance of location | GO:0051235 | 89 | 0.050 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.049 | |
| hormone metabolic process | GO:0042445 | 86 | 0.047 | |
| cofactor transport | GO:0051181 | 4 | 0.046 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.046 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.045 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.044 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.043 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.043 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.043 | |
| response to insulin | GO:0032868 | 100 | 0.042 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.042 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.042 | |
| humoral immune response | GO:0006959 | 57 | 0.041 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.041 | Human |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.041 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.040 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.040 | |
| lipid localization | GO:0010876 | 126 | 0.040 | |
| hexose metabolic process | GO:0019318 | 98 | 0.039 | Mouse |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.039 | Mouse |
| innate immune response | GO:0045087 | 157 | 0.038 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.038 | |
| iron coordination entity transport | GO:1901678 | 5 | 0.038 | |
| low density lipoprotein particle remodeling | GO:0034374 | 2 | 0.038 | |
| response to metal ion | GO:0010038 | 47 | 0.038 | Human |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.037 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.037 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.037 | Human |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.036 | |
| regulation of system process | GO:0044057 | 200 | 0.036 | Human |
| endothelial cell apoptotic process | GO:0072577 | 9 | 0.036 | Human |
| response to inorganic substance | GO:0010035 | 96 | 0.034 | Human |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.034 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.034 | Human |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.034 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.033 | Human |
| retinoic acid metabolic process | GO:0042573 | 12 | 0.033 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.033 | |
| regulation of secretion | GO:0051046 | 274 | 0.033 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.033 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.033 | |
| gliogenesis | GO:0042063 | 141 | 0.033 | |
| regulation of cell motility | GO:2000145 | 236 | 0.033 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.032 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.032 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.032 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.032 | |
| response to oxidative stress | GO:0006979 | 123 | 0.032 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.032 | |
| lipid homeostasis | GO:0055088 | 63 | 0.032 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.031 | |
| male gamete generation | GO:0048232 | 285 | 0.031 | |
| protein activation cascade | GO:0072376 | 19 | 0.031 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.031 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.030 | |
| regulation of transcription from rna polymerase ii promoter in response to iron | GO:0034395 | 3 | 0.030 | |
| cellular response to lipid | GO:0071396 | 145 | 0.030 | |
| cellular homeostasis | GO:0019725 | 240 | 0.030 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.030 | Mouse |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.030 | |
| cholesterol transport | GO:0030301 | 38 | 0.030 | |
| response to nutrient levels | GO:0031667 | 109 | 0.030 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.030 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.029 | |
| regulation of protein activation cascade | GO:2000257 | 7 | 0.029 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.029 | |
| spermatogenesis | GO:0007283 | 284 | 0.029 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.029 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.029 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.029 | |
| regulation of ossification | GO:0030278 | 112 | 0.029 | |
| cytokine production | GO:0001816 | 319 | 0.028 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.028 | Human |
| protein catabolic process | GO:0030163 | 221 | 0.028 | |
| regulation of coagulation | GO:0050818 | 31 | 0.028 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.028 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.028 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.028 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.027 | |
| response to stilbenoid | GO:0035634 | 22 | 0.027 | Mouse |
| cholesterol esterification | GO:0034435 | 3 | 0.027 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.027 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.027 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.027 | Rat |
| sterol transport | GO:0015918 | 38 | 0.027 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.026 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.026 | Human |
| protein n linked glycosylation | GO:0006487 | 12 | 0.026 | |
| heme transport | GO:0015886 | 2 | 0.026 | |
| glial cell differentiation | GO:0010001 | 131 | 0.026 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.026 | |
| cholesterol efflux | GO:0033344 | 24 | 0.026 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.026 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.025 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.025 | |
| negative regulation of gluconeogenesis | GO:0045721 | 9 | 0.025 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.025 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.025 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.025 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.025 | Human |
| negative regulation of complement activation | GO:0045916 | 3 | 0.024 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.024 | |
| multicellular organism growth | GO:0035264 | 161 | 0.024 | |
| tissue remodeling | GO:0048771 | 102 | 0.024 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.024 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 9 | 0.024 | Human |
| activation of immune response | GO:0002253 | 138 | 0.024 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.024 | Human |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.024 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.024 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.024 | |
| response to peptide | GO:1901652 | 136 | 0.023 | |
| negative regulation of wound healing | GO:0061045 | 14 | 0.023 | |
| response to peptide hormone | GO:0043434 | 127 | 0.023 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.023 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.023 | Mouse |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.023 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.023 | |
| regulation of protein kinase c activity | GO:1900019 | 1 | 0.023 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.023 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.023 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.023 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.023 | Mouse |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.023 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.023 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.023 | Human |
| lipid storage | GO:0019915 | 36 | 0.022 | |
| regulation of protein stability | GO:0031647 | 52 | 0.022 | |
| myosin filament organization | GO:0031033 | 3 | 0.022 | |
| response to steroid hormone | GO:0048545 | 56 | 0.022 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.022 | |
| endothelial cell migration | GO:0043542 | 44 | 0.022 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.022 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.022 | Human |
| ossification | GO:0001503 | 216 | 0.022 | |
| cholesterol import | GO:0070508 | 2 | 0.022 | |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.021 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.021 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.021 | |
| glycosylation | GO:0070085 | 62 | 0.021 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.021 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.021 | Human |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.021 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.021 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.021 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.021 | |
| negative regulation of growth | GO:0045926 | 99 | 0.021 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.020 | |
| cell junction organization | GO:0034330 | 77 | 0.020 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.020 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.020 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.020 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.020 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.020 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.020 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.020 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.020 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.020 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.020 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.020 | Human |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.020 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.020 | |
| chondrocyte development | GO:0002063 | 24 | 0.020 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.019 | Human |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.019 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.019 | Human |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.019 | Human |
| vascular process in circulatory system | GO:0003018 | 62 | 0.019 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.019 | |
| urogenital system development | GO:0001655 | 261 | 0.019 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.019 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.019 | |
| cation homeostasis | GO:0055080 | 212 | 0.019 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.019 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.019 | |
| regulation of phosphatidylcholine biosynthetic process | GO:2001245 | 2 | 0.019 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.019 | |
| lipid modification | GO:0030258 | 65 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| steroid esterification | GO:0034433 | 3 | 0.019 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.019 | Human |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.018 | |
| cell growth | GO:0016049 | 130 | 0.018 | |
| gland development | GO:0048732 | 330 | 0.018 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.018 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.018 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.018 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.018 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.018 | |
| cellular response to peptide | GO:1901653 | 92 | 0.018 | |
| regulation of lipoprotein metabolic process | GO:0050746 | 4 | 0.018 | |
| regulation of tube size | GO:0035150 | 57 | 0.018 | Human |
| response to oxygen levels | GO:0070482 | 62 | 0.018 | |
| phosphatidylcholine biosynthetic process | GO:0006656 | 8 | 0.018 | |
| zymogen activation | GO:0031638 | 41 | 0.018 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.018 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.018 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.018 | Mouse |
| regulation of cell growth | GO:0001558 | 91 | 0.018 | |
| positive regulation of complement activation | GO:0045917 | 2 | 0.017 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.017 | |
| actin filament based movement | GO:0030048 | 23 | 0.017 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.017 | |
| renal system development | GO:0072001 | 225 | 0.017 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.017 | |
| cell cell junction organization | GO:0045216 | 72 | 0.017 | |
| tissue migration | GO:0090130 | 68 | 0.017 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.017 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.017 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.017 | Human |
| protein glycosylation | GO:0006486 | 55 | 0.017 | |
| steroid metabolic process | GO:0008202 | 119 | 0.017 | Mouse |
| response to chromate | GO:0046687 | 1 | 0.017 | |
| response to testosterone | GO:0033574 | 3 | 0.017 | |
| glucose metabolic process | GO:0006006 | 92 | 0.017 | Mouse |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.017 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.017 | |
| exocytosis | GO:0006887 | 121 | 0.017 | Human |
| cellular ion homeostasis | GO:0006873 | 165 | 0.017 | |
| phospholipid homeostasis | GO:0055091 | 6 | 0.017 | |
| liver development | GO:0001889 | 66 | 0.017 | |
| epithelial cell development | GO:0002064 | 159 | 0.017 | |
| negative regulation of toll signaling pathway | GO:0045751 | 1 | 0.017 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.016 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.016 | |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061179 | 4 | 0.016 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.016 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.016 | |
| protein secretion | GO:0009306 | 111 | 0.016 | Human |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.016 | |
| skeletal system development | GO:0001501 | 356 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.016 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.016 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | |
| adaptive immune response | GO:0002250 | 155 | 0.016 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.016 | |
| sterol esterification | GO:0034434 | 3 | 0.016 | |
| forebrain development | GO:0030900 | 302 | 0.016 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.016 | |
| rhythmic process | GO:0048511 | 174 | 0.016 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.016 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.016 | |
| regulation of cell activation | GO:0050865 | 289 | 0.016 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.016 | |
| myosin filament assembly | GO:0031034 | 2 | 0.016 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.016 | |
| stem cell differentiation | GO:0048863 | 268 | 0.016 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.016 | Mouse |
| gluconeogenesis | GO:0006094 | 39 | 0.016 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.016 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.016 | Mouse |
| 9 cis retinoic acid biosynthetic process | GO:0042904 | 5 | 0.016 | |
| platelet activation | GO:0030168 | 40 | 0.015 | Human |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.015 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.015 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.015 | |
| axonogenesis | GO:0007409 | 274 | 0.015 | |
| peptide secretion | GO:0002790 | 114 | 0.015 | Human |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.015 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.015 | |
| gonad development | GO:0008406 | 141 | 0.015 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.015 | |
| organelle assembly | GO:0070925 | 177 | 0.015 | |
| sterol import | GO:0035376 | 2 | 0.015 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.015 | |
| response to iron ion | GO:0010039 | 4 | 0.015 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.015 | Human |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.015 | |
| extracellular structure organization | GO:0043062 | 148 | 0.015 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.015 | |
| positive regulation of phosphatidylinositol 3 kinase signaling | GO:0014068 | 20 | 0.015 | |
| organ regeneration | GO:0031100 | 2 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.015 | Human |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.015 | |
| regulation of protein transport | GO:0051223 | 163 | 0.015 | Human |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.015 | Human |
| protein oligomerization | GO:0051259 | 67 | 0.015 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.015 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.015 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.015 | |
| anion homeostasis | GO:0055081 | 16 | 0.015 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.015 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.015 | |
| female sex differentiation | GO:0046660 | 84 | 0.015 | |
| muscle system process | GO:0003012 | 141 | 0.014 | |
| macromolecular complex remodeling | GO:0034367 | 6 | 0.014 | |
| peptide transport | GO:0015833 | 133 | 0.014 | Human |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.014 | |
| bone development | GO:0060348 | 120 | 0.014 | |
| organelle localization | GO:0051640 | 179 | 0.014 | |
| endocytosis | GO:0006897 | 168 | 0.014 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.014 | |
| negative regulation of cytokine secretion involved in immune response | GO:0002740 | 1 | 0.014 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.014 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.014 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.014 | |
| artery development | GO:0060840 | 53 | 0.014 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.014 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.014 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.014 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.014 | |
| kidney development | GO:0001822 | 213 | 0.014 | |
| neuron death | GO:0070997 | 154 | 0.014 | |
| regulation of toll signaling pathway | GO:0008592 | 1 | 0.014 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.014 | |
| lipid transport | GO:0006869 | 98 | 0.014 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.014 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.014 | |
| astrocyte activation | GO:0048143 | 2 | 0.014 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.014 | |
| negative regulation of carbohydrate metabolic process | GO:0045912 | 19 | 0.013 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.013 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.013 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.013 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.013 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.013 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.013 | |
| tissue regeneration | GO:0042246 | 22 | 0.013 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.013 | |
| connective tissue development | GO:0061448 | 179 | 0.013 | Mouse |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.013 | Human |
| triglyceride homeostasis | GO:0070328 | 15 | 0.013 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.013 | |
| regulation of cell migration | GO:0030334 | 219 | 0.013 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.013 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.013 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.013 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.013 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.013 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.013 | |
| 9 cis retinoic acid metabolic process | GO:0042905 | 5 | 0.013 | |
| collagen fibril organization | GO:0030199 | 32 | 0.013 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.013 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.013 | |
| insulin processing | GO:0030070 | 2 | 0.013 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.013 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.013 | |
| membrane organization | GO:0061024 | 245 | 0.013 | |
| complement activation lectin pathway | GO:0001867 | 5 | 0.013 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.013 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.013 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.013 | |
| organ growth | GO:0035265 | 117 | 0.013 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.012 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.012 | |
| regulation of action potential | GO:0098900 | 4 | 0.012 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.012 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.012 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.012 | |
| blood circulation | GO:0008015 | 195 | 0.012 | Human |
| regulation of intracellular transport | GO:0032386 | 159 | 0.012 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.012 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.012 | |
| amide transport | GO:0042886 | 138 | 0.012 | Human |
| positive regulation of secretion | GO:0051047 | 130 | 0.012 | Human |
| acute inflammatory response | GO:0002526 | 41 | 0.012 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.012 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.012 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.012 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.012 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.012 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.012 | |
| organelle fission | GO:0048285 | 170 | 0.012 | |
| foramen ovale closure | GO:0035922 | 1 | 0.012 | |
| ovarian follicle rupture | GO:0001543 | 2 | 0.012 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.012 | |
| epithelium migration | GO:0090132 | 63 | 0.012 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.012 | |
| skin development | GO:0043588 | 220 | 0.012 | |
| anion transport | GO:0006820 | 177 | 0.012 | |
| regulation of complement activation classical pathway | GO:0030450 | 1 | 0.012 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.012 | |
| regulation of fatty acid beta oxidation | GO:0031998 | 1 | 0.012 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.012 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.012 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.012 | |
| developmental maturation | GO:0021700 | 193 | 0.012 | |
